Quick Search

 

 


 

 

Result Summary for 217744/035

Result Summary
Protocol ID: 217744/035
Clinical Study ID: 217744/035
Official Title: A booster vaccination study of one dose of GSK’s DTPa HBV IPV vaccine, coadministered with 2 formulations of GSK’s Hib conjugate vaccine, either mixed or injected in 2 concomitant injections, in healthy children who participated in Study 217744/011 (DTPa-HBV-IPV-011) or 217744/016 (DTPa-HBV-IPV-016)
Phase: Phase 2
Study Indications or Diseases:
  • Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio, Hib
Generic Name: Haemophilus influenzae Type b Vaccine
Trade/Product Name: Hiberix;Hiberix
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.